Drug discovery team
Our Drug Discovery Institute couples the biological expertise of international collaborators with innovative in-house drug discovery expertise. Our Institute houses dedicated biology, chemistry, pharmacology and screening teams to evaluate promising new targets. We then establish assays to screen compound libraries for hits against these targets and improve hits into potent and selective lead compounds. This provides the basis for the development of the next generation of medicines to treat neurodegeneration.
| Biology | |
|---|---|
| Head of Biology: | Jamie Bilsland |
| Scientists: | Sarah Jolly Lorenza Magno Verena Lang Georgie Lines Alexandra van Ingelgom Daniel Bull (PhD Student) |
| Pharmacology and Screening | |
|---|---|
| Head of Pharmacology and Screening: | Magda Bictash |
| Scientists: | Artur Costa Emma Armstrong Amy Monaghan Skye Stuart Fiona Jeganathan Kathryn Costelloe Sarah Frew |
| Chemistry | |
|---|---|
| Head of Chemistry: | Paul Fish |
| Scientists: | Hannah Woodward Ben Atkinson Jim Sipthorp David Steadman Will Mahy Elliott Bayle Nicky Willis Freed Svensson |